Yiran Meng

Also affiliated with John Radcliffe Hospital, University of Oxford, MRC Weatherall Institute of Molecular Medicine, Cube Technology (United States), MRC Human Immunology Unit, Beijing Children’s Hospital, Beijing YouAn Hospital, Zhejiang University of Technology

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer”.

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02206-x

N/A

0.327DataRank · unranked

6 citations

Chunxiao Liu, Meisi Yan, Cong Chen, Yu Cheng, Yaohui Chen +20 more